Orexo’s partner Trinity Health today announces the availability of vorvida® and deprexis® to patients
Uppsala, Sweden – September 7, 2022 – Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY) today announces the Integrated Healthcare System, Trinity Health in North Dakota, in partnership with Orexo, is expanding patient access to digital therapeutics. Trinity Health will now offer Orexo’s evidence-based digital therapies vorvida® and deprexis® to help patients manage depression and excessive drinking. During the last year, Orexo and Trinity Health have collaborated to establish new administrative processes and support systems to ensure effective patient access to these innovative digital